View ValuationNingxia Baofeng Energy Group 将来の成長Future 基準チェック /26Ningxia Baofeng Energy Group利益と収益がそれぞれ年間12.1%と8.4%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に25.2% 12.7%なると予測されています。主要情報12.1%収益成長率12.69%EPS成長率Chemicals 収益成長28.8%収益成長率8.4%将来の株主資本利益率25.23%アナリストカバレッジGood最終更新日14 Jul 2026今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesBuy Or Sell Opportunity • Jul 07Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 29% to CN¥20.39. The fair value is estimated to be CN¥26.27, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 21% over the last 3 years. Earnings per share has grown by 33%. Revenue is forecast to grow by 25% in 2 years. Earnings are forecast to grow by 35% in the next 2 years.お知らせ • Jun 30Ningxia Baofeng Energy Group Co., Ltd. to Report First Half, 2026 Results on Aug 13, 2026Ningxia Baofeng Energy Group Co., Ltd. announced that they will report first half, 2026 results on Aug 13, 2026Buy Or Sell Opportunity • Jun 15Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 32% to CN¥22.30. The fair value is estimated to be CN¥27.92, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 21% over the last 3 years. Earnings per share has grown by 33%. Revenue is forecast to grow by 25% in 2 years. Earnings are forecast to grow by 35% in the next 2 years.Board Change • May 20Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 6 non-independent directors. Independent Director Yao Zhong Li was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Mar 30Ningxia Baofeng Energy Group Co., Ltd. to Report Q1, 2026 Results on Apr 24, 2026Ningxia Baofeng Energy Group Co., Ltd. announced that they will report Q1, 2026 results on Apr 24, 2026お知らせ • Mar 12Ningxia Baofeng Energy Group Co., Ltd., Annual General Meeting, Apr 03, 2026Ningxia Baofeng Energy Group Co., Ltd., Annual General Meeting, Apr 03, 2026, at 14:00 China Standard Time. Location: 4F, No. 1, Lijing North Street, Yinchuan, Ningxia Chinaお知らせ • Dec 26Ningxia Baofeng Energy Group Co., Ltd. to Report Fiscal Year 2025 Results on Mar 06, 2026Ningxia Baofeng Energy Group Co., Ltd. announced that they will report fiscal year 2025 results on Mar 06, 2026お知らせ • Sep 30Ningxia Baofeng Energy Group Co., Ltd. to Report Q3, 2025 Results on Oct 24, 2025Ningxia Baofeng Energy Group Co., Ltd. announced that they will report Q3, 2025 results on Oct 24, 2025お知らせ • Jun 30Ningxia Baofeng Energy Group Co., Ltd. to Report First Half, 2025 Results on Aug 08, 2025Ningxia Baofeng Energy Group Co., Ltd. announced that they will report first half, 2025 results on Aug 08, 2025お知らせ • Jun 24Ningxia Baofeng Energy Group Co., Ltd.(SHSE:600989) dropped from Shanghai Stock Exchange 180 Value IndexNingxia Baofeng Energy Group Co., Ltd. has been removed from Shanghai Stock Exchange 180 Value Index .お知らせ • May 15Ningxia Baofeng Energy Group Co., Ltd. (SHSE:600989) announces an Equity Buyback for CNY 2,000 million worth of its shares.Ningxia Baofeng Energy Group Co., Ltd. (SHSE:600989) announces a share repurchase program. Under the program, the company will repurchase up to CNY 2,000 million worth of class A shares. The shares will be repurchased at a price of not more than CNY 22.80 per share. The shares purchased will be used for employee stock ownership plans and equity incentives. The program will be funded out of the company's own funds or self-raised funds. The program will be valid till May 13, 2026.お知らせ • Mar 28Ningxia Baofeng Energy Group Co., Ltd. to Report Q1, 2025 Results on Apr 23, 2025Ningxia Baofeng Energy Group Co., Ltd. announced that they will report Q1, 2025 results on Apr 23, 2025お知らせ • Mar 12Ningxia Baofeng Energy Group Co., Ltd., Annual General Meeting, Apr 02, 2025Ningxia Baofeng Energy Group Co., Ltd., Annual General Meeting, Apr 02, 2025, at 14:00 China Standard Time. Location: 4F, No. 1, Lijing North Street, Yinchuan, Ningxia Chinaお知らせ • Dec 27Ningxia Baofeng Energy Group Co., Ltd. to Report Fiscal Year 2024 Results on Mar 12, 2025Ningxia Baofeng Energy Group Co., Ltd. announced that they will report fiscal year 2024 results on Mar 12, 2025Reported Earnings • Nov 01Third quarter 2024 earnings released: EPS: CN¥0.17 (vs CN¥0.22 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.17 (down from CN¥0.22 in 3Q 2023). Revenue: CN¥7.38b (flat on 3Q 2023). Net income: CN¥1.23b (down 25% from 3Q 2023). Profit margin: 17% (down from 22% in 3Q 2023). Revenue is forecast to grow 27% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Sep 30Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥17.35, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 16% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥29.08 per share.お知らせ • Sep 30Ningxia Baofeng Energy Group Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024Ningxia Baofeng Energy Group Co., Ltd. announced that they will report Q3, 2024 results on Oct 31, 2024Reported Earnings • Aug 14Second quarter 2024 earnings released: EPS: CN¥0.26 (vs CN¥0.15 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.26 (up from CN¥0.15 in 2Q 2023). Revenue: CN¥8.67b (up 36% from 2Q 2023). Net income: CN¥1.88b (up 76% from 2Q 2023). Profit margin: 22% (up from 17% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 27% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 7% per year whereas the company’s share price has fallen by 3% per year.お知らせ • Jun 29Ningxia Baofeng Energy Group Co., Ltd. to Report First Half, 2024 Results on Aug 13, 2024Ningxia Baofeng Energy Group Co., Ltd. announced that they will report first half, 2024 results on Aug 13, 2024お知らせ • Jun 02Ningxia Baofeng Energy Group Co., Ltd., Annual General Meeting, Jun 21, 2024Ningxia Baofeng Energy Group Co., Ltd., Annual General Meeting, Jun 21, 2024, at 14:00 China Standard Time.Reported Earnings • Apr 27First quarter 2024 earnings released: EPS: CN¥0.19 (vs CN¥0.16 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.19 (up from CN¥0.16 in 1Q 2023). Revenue: CN¥8.23b (up 22% from 1Q 2023). Net income: CN¥1.42b (up 20% from 1Q 2023). Profit margin: 17% (in line with 1Q 2023). Revenue is forecast to grow 27% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.お知らせ • Mar 29Ningxia Baofeng Energy Group Co., Ltd. to Report Q1, 2024 Results on Apr 26, 2024Ningxia Baofeng Energy Group Co., Ltd. announced that they will report Q1, 2024 results on Apr 26, 2024Reported Earnings • Mar 22Full year 2023 earnings released: EPS: CN¥0.77 (vs CN¥0.86 in FY 2022)Full year 2023 results: EPS: CN¥0.77 (down from CN¥0.86 in FY 2022). Revenue: CN¥29.1b (up 2.5% from FY 2022). Net income: CN¥5.65b (down 10% from FY 2022). Profit margin: 19% (down from 22% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 27% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 3% per year whereas the company’s share price has increased by 1% per year.お知らせ • Dec 30Ningxia Baofeng Energy Group Co., Ltd. to Report Fiscal Year 2023 Results on Mar 22, 2024Ningxia Baofeng Energy Group Co., Ltd. announced that they will report fiscal year 2023 results on Mar 22, 2024New Risk • Aug 26New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 17% Last year net profit margin: 27% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (20% accrual ratio). Minor Risks High level of debt (47% net debt to equity). Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (17% net profit margin).Reported Earnings • Mar 10Full year 2022 earnings released: EPS: CN¥0.86 (vs CN¥0.97 in FY 2021)Full year 2022 results: EPS: CN¥0.86 (down from CN¥0.97 in FY 2021). Revenue: CN¥28.4b (up 22% from FY 2021). Net income: CN¥6.30b (down 11% from FY 2021). Profit margin: 22% (down from 30% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 24% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 23% per year whereas the company’s share price has increased by 19% per year.Board Change • Nov 16Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 10 experienced directors. 1 highly experienced director. 3 independent directors (6 non-independent directors). Independent Director Longhu Liang was the last independent director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Oct 28Third quarter 2022 earnings released: EPS: CN¥0.18 (vs CN¥0.22 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.18 (down from CN¥0.22 in 3Q 2021). Revenue: CN¥7.09b (up 24% from 3Q 2021). Net income: CN¥1.36b (down 14% from 3Q 2021). Profit margin: 19% (down from 28% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 30% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Sep 22Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥14.66, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 15x in the Chemicals industry in China. Total returns to shareholders of 57% over the past three years.Reported Earnings • Aug 11Second quarter 2022 earnings released: EPS: CN¥0.31 (vs CN¥0.27 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.31 (up from CN¥0.27 in 2Q 2021). Revenue: CN¥7.88b (up 44% from 2Q 2021). Net income: CN¥2.27b (up 13% from 2Q 2021). Profit margin: 29% (down from 37% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 15%, compared to a 41% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth.Board Change • Apr 27Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 10 experienced directors. 1 highly experienced director. 3 independent directors (6 non-independent directors). Independent Director Longhu Liang was the last independent director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Mar 10Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: EPS: CN¥0.97 (up from CN¥0.63 in FY 2020). Revenue: CN¥23.3b (up 46% from FY 2020). Net income: CN¥7.07b (up 53% from FY 2020). Profit margin: 30% (up from 29% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 13%. Over the next year, revenue is forecast to grow 4.6%, compared to a 47% growth forecast for the industry in China.Valuation Update With 7 Day Price Move • Nov 22Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥16.27, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 29% over the past year.Reported Earnings • Oct 28Third quarter 2021 earnings released: EPS CN¥0.22 (vs CN¥0.14 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were flat. Third quarter 2021 results: Revenue: CN¥5.73b (up 52% from 3Q 2020). Net income: CN¥1.58b (up 50% from 3Q 2020). Profit margin: 28% (in line with 3Q 2020).Reported Earnings • Aug 11Second quarter 2021 earnings released: EPS CN¥0.27 (vs CN¥0.18 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥5.49b (up 40% from 2Q 2020). Net income: CN¥2.01b (up 58% from 2Q 2020). Profit margin: 37% (up from 33% in 2Q 2020). The increase in margin was driven by higher revenue.Reported Earnings • Apr 20First quarter 2021 earnings released: EPS CN¥0.24 (vs CN¥0.11 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥4.98b (up 38% from 1Q 2020). Net income: CN¥1.73b (up 110% from 1Q 2020). Profit margin: 35% (up from 23% in 1Q 2020). The increase in margin was driven by higher revenue.Valuation Update With 7 Day Price Move • Mar 17Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥17.12, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 22x in the Chemicals industry in China. Total returns to shareholders of 105% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥12.41 per share.Analyst Estimate Surprise Post Earnings • Mar 05Revenue misses expectationsRevenue missed analyst estimates by 0.3%. Over the next year, revenue is forecast to grow 15%, compared to a 51% growth forecast for the Chemicals industry in China.Reported Earnings • Mar 05Full year 2020 earnings released: EPS CN¥0.63 (vs CN¥0.54 in FY 2019)The company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: CN¥15.9b (up 17% from FY 2019). Net income: CN¥4.62b (up 22% from FY 2019). Profit margin: 29% (in line with FY 2019).Valuation Update With 7 Day Price Move • Feb 04Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥18.53, the stock is trading at a trailing P/E ratio of 33.2x, up from the previous P/E ratio of 28.4x. This compares to an average P/E of 35x in the Chemicals industry in China. Total returns to shareholders over the past year are 137%.Is New 90 Day High Low • Jan 25New 90-day high: CN¥15.77The company is up 46% from its price of CN¥10.78 on 28 October 2020. The Chinese market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 25% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥17.12 per share.Valuation Update With 7 Day Price Move • Jan 07Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥13.65, the stock is trading at a trailing P/E ratio of 24.5x, up from the previous P/E ratio of 21x. This compares to an average P/E of 36x in the Chemicals industry in China. Total returns to shareholders over the past year are 47%.Is New 90 Day High Low • Jan 06New 90-day high: CN¥13.38The company is up 31% from its price of CN¥10.21 on 09 October 2020. The Chinese market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 18% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥17.07 per share.Valuation Update With 7 Day Price Move • Nov 23Market bids up stock over the past weekAfter last week's 17% share price gain to CN¥12.85, the stock is trading at a trailing P/E ratio of 22.5x, up from the previous P/E ratio of 19.3x. This compares to an average P/E of 40x in the Chemicals industry in China. Total returns to shareholders over the past year are 41%.Is New 90 Day High Low • Nov 23New 90-day high: CN¥12.85The company is up 2.0% from its price of CN¥12.66 on 25 August 2020. The Chinese market is down 1.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥15.27 per share.Is New 90 Day High Low • Oct 30New 90-day low: CN¥10.17The company is down 1.0% from its price of CN¥10.32 on 31 July 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥14.72 per share.Reported Earnings • Oct 26Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥4.12b, largely unchanged from the prior year. Total revenue was CN¥15.1b over the last 12 months, up 12% from the prior year.業績と収益の成長予測XSSC:600989 - アナリストの将来予測と過去の財務データ ( )CNY Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/202865,15018,29014,26024,452712/31/202763,10317,17118,46123,827812/31/202659,95216,14423,63925,41583/31/202650,50412,56012,57718,997N/A12/31/202548,03811,33610,20816,851N/A9/30/202544,25310,7459,86116,700N/A6/30/202538,9058,7354,04812,742N/A3/31/202535,5277,347-1,73710,533N/A12/31/202432,9836,332-2,6318,898N/A9/30/202433,0096,297-3,3908,788N/A6/30/202432,9436,699-4,0628,753N/A3/31/202430,6295,886-2,3518,546N/A12/31/202329,1365,651-4,1508,693N/A9/30/202327,3464,821-4,9157,462N/A6/30/202327,1254,545-4,6506,714N/A3/31/202328,6485,741-3,9197,173N/A12/31/202228,4306,303-3,3516,626N/A9/30/202228,5897,125-2,1376,791N/A6/30/202227,2287,352-2986,969N/A3/31/202224,8357,0891946,194N/A12/31/202123,3007,0701,1316,488N/A9/30/202120,8256,7891,1816,020N/A6/30/202118,8746,2642,1406,131N/A3/31/202117,2975,5292,3335,570N/A12/31/202015,9284,6232,6105,184N/A9/30/202015,1214,1212,0334,930N/A6/30/202014,5694,0057854,561N/A3/31/202013,9843,603-3983,983N/A12/31/201913,5683,802N/A3,573N/A9/30/201913,5094,140N/A3,415N/A6/30/201913,6304,217N/A3,717N/A3/31/201913,1213,880N/A3,445N/A12/31/201813,0523,696N/A3,265N/A9/30/201812,5153,153N/A2,061N/A6/30/201812,5253,009N/A2,960N/A3/31/201812,6003,155N/A2,942N/A12/31/201712,3012,923N/A3,016N/A9/30/201711,8422,669N/A2,990N/A6/30/201710,7332,553N/A1,669N/A3/31/20179,2102,077N/A2,564N/A12/31/20168,0271,718N/A1,772N/A9/30/20166,5101,442N/A2,399N/A6/30/20166,3751,434N/A1,977N/A3/31/20167,0001,623N/A2,689N/A12/31/20157,0811,515N/A2,490N/A9/30/20156,6431,347N/A3,686N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 600989の予測収益成長率 (年間12.1% ) は 貯蓄率 ( 2.4% ) を上回っています。収益対市場: 600989の収益 ( 12.1% ) CN市場 ( 26% ) よりも低い成長が予測されています。高成長収益: 600989の収益は増加すると予測されていますが、大幅には増加しません。収益対市場: 600989の収益 ( 8.4% ) CN市場 ( 16% ) よりも低い成長が予測されています。高い収益成長: 600989の収益 ( 8.4% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 600989の 自己資本利益率 は、3年後には高くなると予測されています ( 25.2 %)成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/23 04:26終値2026/07/23 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Ningxia Baofeng Energy Group Co., Ltd. 8 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。14 アナリスト機関Wang PengChina Galaxy Securities Co., Ltd.Kaiming FuChina International Capital Corporation LimitedZhe WangCitic Securities Co., Ltd.11 その他のアナリストを表示
Buy Or Sell Opportunity • Jul 07Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 29% to CN¥20.39. The fair value is estimated to be CN¥26.27, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 21% over the last 3 years. Earnings per share has grown by 33%. Revenue is forecast to grow by 25% in 2 years. Earnings are forecast to grow by 35% in the next 2 years.
お知らせ • Jun 30Ningxia Baofeng Energy Group Co., Ltd. to Report First Half, 2026 Results on Aug 13, 2026Ningxia Baofeng Energy Group Co., Ltd. announced that they will report first half, 2026 results on Aug 13, 2026
Buy Or Sell Opportunity • Jun 15Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 32% to CN¥22.30. The fair value is estimated to be CN¥27.92, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 21% over the last 3 years. Earnings per share has grown by 33%. Revenue is forecast to grow by 25% in 2 years. Earnings are forecast to grow by 35% in the next 2 years.
Board Change • May 20Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 6 non-independent directors. Independent Director Yao Zhong Li was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Mar 30Ningxia Baofeng Energy Group Co., Ltd. to Report Q1, 2026 Results on Apr 24, 2026Ningxia Baofeng Energy Group Co., Ltd. announced that they will report Q1, 2026 results on Apr 24, 2026
お知らせ • Mar 12Ningxia Baofeng Energy Group Co., Ltd., Annual General Meeting, Apr 03, 2026Ningxia Baofeng Energy Group Co., Ltd., Annual General Meeting, Apr 03, 2026, at 14:00 China Standard Time. Location: 4F, No. 1, Lijing North Street, Yinchuan, Ningxia China
お知らせ • Dec 26Ningxia Baofeng Energy Group Co., Ltd. to Report Fiscal Year 2025 Results on Mar 06, 2026Ningxia Baofeng Energy Group Co., Ltd. announced that they will report fiscal year 2025 results on Mar 06, 2026
お知らせ • Sep 30Ningxia Baofeng Energy Group Co., Ltd. to Report Q3, 2025 Results on Oct 24, 2025Ningxia Baofeng Energy Group Co., Ltd. announced that they will report Q3, 2025 results on Oct 24, 2025
お知らせ • Jun 30Ningxia Baofeng Energy Group Co., Ltd. to Report First Half, 2025 Results on Aug 08, 2025Ningxia Baofeng Energy Group Co., Ltd. announced that they will report first half, 2025 results on Aug 08, 2025
お知らせ • Jun 24Ningxia Baofeng Energy Group Co., Ltd.(SHSE:600989) dropped from Shanghai Stock Exchange 180 Value IndexNingxia Baofeng Energy Group Co., Ltd. has been removed from Shanghai Stock Exchange 180 Value Index .
お知らせ • May 15Ningxia Baofeng Energy Group Co., Ltd. (SHSE:600989) announces an Equity Buyback for CNY 2,000 million worth of its shares.Ningxia Baofeng Energy Group Co., Ltd. (SHSE:600989) announces a share repurchase program. Under the program, the company will repurchase up to CNY 2,000 million worth of class A shares. The shares will be repurchased at a price of not more than CNY 22.80 per share. The shares purchased will be used for employee stock ownership plans and equity incentives. The program will be funded out of the company's own funds or self-raised funds. The program will be valid till May 13, 2026.
お知らせ • Mar 28Ningxia Baofeng Energy Group Co., Ltd. to Report Q1, 2025 Results on Apr 23, 2025Ningxia Baofeng Energy Group Co., Ltd. announced that they will report Q1, 2025 results on Apr 23, 2025
お知らせ • Mar 12Ningxia Baofeng Energy Group Co., Ltd., Annual General Meeting, Apr 02, 2025Ningxia Baofeng Energy Group Co., Ltd., Annual General Meeting, Apr 02, 2025, at 14:00 China Standard Time. Location: 4F, No. 1, Lijing North Street, Yinchuan, Ningxia China
お知らせ • Dec 27Ningxia Baofeng Energy Group Co., Ltd. to Report Fiscal Year 2024 Results on Mar 12, 2025Ningxia Baofeng Energy Group Co., Ltd. announced that they will report fiscal year 2024 results on Mar 12, 2025
Reported Earnings • Nov 01Third quarter 2024 earnings released: EPS: CN¥0.17 (vs CN¥0.22 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.17 (down from CN¥0.22 in 3Q 2023). Revenue: CN¥7.38b (flat on 3Q 2023). Net income: CN¥1.23b (down 25% from 3Q 2023). Profit margin: 17% (down from 22% in 3Q 2023). Revenue is forecast to grow 27% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Sep 30Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥17.35, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 16% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥29.08 per share.
お知らせ • Sep 30Ningxia Baofeng Energy Group Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024Ningxia Baofeng Energy Group Co., Ltd. announced that they will report Q3, 2024 results on Oct 31, 2024
Reported Earnings • Aug 14Second quarter 2024 earnings released: EPS: CN¥0.26 (vs CN¥0.15 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.26 (up from CN¥0.15 in 2Q 2023). Revenue: CN¥8.67b (up 36% from 2Q 2023). Net income: CN¥1.88b (up 76% from 2Q 2023). Profit margin: 22% (up from 17% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 27% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 7% per year whereas the company’s share price has fallen by 3% per year.
お知らせ • Jun 29Ningxia Baofeng Energy Group Co., Ltd. to Report First Half, 2024 Results on Aug 13, 2024Ningxia Baofeng Energy Group Co., Ltd. announced that they will report first half, 2024 results on Aug 13, 2024
お知らせ • Jun 02Ningxia Baofeng Energy Group Co., Ltd., Annual General Meeting, Jun 21, 2024Ningxia Baofeng Energy Group Co., Ltd., Annual General Meeting, Jun 21, 2024, at 14:00 China Standard Time.
Reported Earnings • Apr 27First quarter 2024 earnings released: EPS: CN¥0.19 (vs CN¥0.16 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.19 (up from CN¥0.16 in 1Q 2023). Revenue: CN¥8.23b (up 22% from 1Q 2023). Net income: CN¥1.42b (up 20% from 1Q 2023). Profit margin: 17% (in line with 1Q 2023). Revenue is forecast to grow 27% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.
お知らせ • Mar 29Ningxia Baofeng Energy Group Co., Ltd. to Report Q1, 2024 Results on Apr 26, 2024Ningxia Baofeng Energy Group Co., Ltd. announced that they will report Q1, 2024 results on Apr 26, 2024
Reported Earnings • Mar 22Full year 2023 earnings released: EPS: CN¥0.77 (vs CN¥0.86 in FY 2022)Full year 2023 results: EPS: CN¥0.77 (down from CN¥0.86 in FY 2022). Revenue: CN¥29.1b (up 2.5% from FY 2022). Net income: CN¥5.65b (down 10% from FY 2022). Profit margin: 19% (down from 22% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 27% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 3% per year whereas the company’s share price has increased by 1% per year.
お知らせ • Dec 30Ningxia Baofeng Energy Group Co., Ltd. to Report Fiscal Year 2023 Results on Mar 22, 2024Ningxia Baofeng Energy Group Co., Ltd. announced that they will report fiscal year 2023 results on Mar 22, 2024
New Risk • Aug 26New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 17% Last year net profit margin: 27% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (20% accrual ratio). Minor Risks High level of debt (47% net debt to equity). Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (17% net profit margin).
Reported Earnings • Mar 10Full year 2022 earnings released: EPS: CN¥0.86 (vs CN¥0.97 in FY 2021)Full year 2022 results: EPS: CN¥0.86 (down from CN¥0.97 in FY 2021). Revenue: CN¥28.4b (up 22% from FY 2021). Net income: CN¥6.30b (down 11% from FY 2021). Profit margin: 22% (down from 30% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 24% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 23% per year whereas the company’s share price has increased by 19% per year.
Board Change • Nov 16Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 10 experienced directors. 1 highly experienced director. 3 independent directors (6 non-independent directors). Independent Director Longhu Liang was the last independent director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Oct 28Third quarter 2022 earnings released: EPS: CN¥0.18 (vs CN¥0.22 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.18 (down from CN¥0.22 in 3Q 2021). Revenue: CN¥7.09b (up 24% from 3Q 2021). Net income: CN¥1.36b (down 14% from 3Q 2021). Profit margin: 19% (down from 28% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 30% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Sep 22Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥14.66, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 15x in the Chemicals industry in China. Total returns to shareholders of 57% over the past three years.
Reported Earnings • Aug 11Second quarter 2022 earnings released: EPS: CN¥0.31 (vs CN¥0.27 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.31 (up from CN¥0.27 in 2Q 2021). Revenue: CN¥7.88b (up 44% from 2Q 2021). Net income: CN¥2.27b (up 13% from 2Q 2021). Profit margin: 29% (down from 37% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 15%, compared to a 41% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth.
Board Change • Apr 27Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 10 experienced directors. 1 highly experienced director. 3 independent directors (6 non-independent directors). Independent Director Longhu Liang was the last independent director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Mar 10Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: EPS: CN¥0.97 (up from CN¥0.63 in FY 2020). Revenue: CN¥23.3b (up 46% from FY 2020). Net income: CN¥7.07b (up 53% from FY 2020). Profit margin: 30% (up from 29% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 13%. Over the next year, revenue is forecast to grow 4.6%, compared to a 47% growth forecast for the industry in China.
Valuation Update With 7 Day Price Move • Nov 22Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥16.27, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 29% over the past year.
Reported Earnings • Oct 28Third quarter 2021 earnings released: EPS CN¥0.22 (vs CN¥0.14 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were flat. Third quarter 2021 results: Revenue: CN¥5.73b (up 52% from 3Q 2020). Net income: CN¥1.58b (up 50% from 3Q 2020). Profit margin: 28% (in line with 3Q 2020).
Reported Earnings • Aug 11Second quarter 2021 earnings released: EPS CN¥0.27 (vs CN¥0.18 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥5.49b (up 40% from 2Q 2020). Net income: CN¥2.01b (up 58% from 2Q 2020). Profit margin: 37% (up from 33% in 2Q 2020). The increase in margin was driven by higher revenue.
Reported Earnings • Apr 20First quarter 2021 earnings released: EPS CN¥0.24 (vs CN¥0.11 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥4.98b (up 38% from 1Q 2020). Net income: CN¥1.73b (up 110% from 1Q 2020). Profit margin: 35% (up from 23% in 1Q 2020). The increase in margin was driven by higher revenue.
Valuation Update With 7 Day Price Move • Mar 17Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥17.12, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 22x in the Chemicals industry in China. Total returns to shareholders of 105% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥12.41 per share.
Analyst Estimate Surprise Post Earnings • Mar 05Revenue misses expectationsRevenue missed analyst estimates by 0.3%. Over the next year, revenue is forecast to grow 15%, compared to a 51% growth forecast for the Chemicals industry in China.
Reported Earnings • Mar 05Full year 2020 earnings released: EPS CN¥0.63 (vs CN¥0.54 in FY 2019)The company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: CN¥15.9b (up 17% from FY 2019). Net income: CN¥4.62b (up 22% from FY 2019). Profit margin: 29% (in line with FY 2019).
Valuation Update With 7 Day Price Move • Feb 04Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥18.53, the stock is trading at a trailing P/E ratio of 33.2x, up from the previous P/E ratio of 28.4x. This compares to an average P/E of 35x in the Chemicals industry in China. Total returns to shareholders over the past year are 137%.
Is New 90 Day High Low • Jan 25New 90-day high: CN¥15.77The company is up 46% from its price of CN¥10.78 on 28 October 2020. The Chinese market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 25% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥17.12 per share.
Valuation Update With 7 Day Price Move • Jan 07Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥13.65, the stock is trading at a trailing P/E ratio of 24.5x, up from the previous P/E ratio of 21x. This compares to an average P/E of 36x in the Chemicals industry in China. Total returns to shareholders over the past year are 47%.
Is New 90 Day High Low • Jan 06New 90-day high: CN¥13.38The company is up 31% from its price of CN¥10.21 on 09 October 2020. The Chinese market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 18% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥17.07 per share.
Valuation Update With 7 Day Price Move • Nov 23Market bids up stock over the past weekAfter last week's 17% share price gain to CN¥12.85, the stock is trading at a trailing P/E ratio of 22.5x, up from the previous P/E ratio of 19.3x. This compares to an average P/E of 40x in the Chemicals industry in China. Total returns to shareholders over the past year are 41%.
Is New 90 Day High Low • Nov 23New 90-day high: CN¥12.85The company is up 2.0% from its price of CN¥12.66 on 25 August 2020. The Chinese market is down 1.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥15.27 per share.
Is New 90 Day High Low • Oct 30New 90-day low: CN¥10.17The company is down 1.0% from its price of CN¥10.32 on 31 July 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥14.72 per share.
Reported Earnings • Oct 26Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥4.12b, largely unchanged from the prior year. Total revenue was CN¥15.1b over the last 12 months, up 12% from the prior year.